Advertisement

Topics

Drugmaker Regeneron's quarterly profit surges 47 pct

08:31 EST 8 Nov 2017 | Topix

Regeneron Pharmaceuticals Inc reported a 47 percent jump in quarterly profit on Wednesday on higher demand for its flagship eye treatment Eylea. The U.S. biotechnology company said net income rose to $388.3 million, or $3.32 per share, in the third quarter ended Sept.

Original Article: Drugmaker Regeneron's quarterly profit surges 47 pct

NEXT ARTICLE

More From BioPortfolio on "Drugmaker Regeneron's quarterly profit surges 47 pct"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...